Fundz
Back to SEC Filings
10-KHIGH RiskDETERIORATING

BioNexus Gene Lab Corp

www.bionexusgenelab.com
Filed: Apr 14, 2026 CIK: 0001737523Health Care
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-K filing content

BioNexus Gene Lab Corp shows significant operational and structural concerns with incomplete filing content, limited business disclosure, and heavy reliance on Malaysian subsidiaries. The filing appears truncated with repeated boilerplate text across sections, suggesting potential disclosure deficiencies and operational challenges.

Red Flags Detected (6)

Incomplete 10-K filing with truncated sections containing only table of contents

Repeated identical boilerplate text across multiple critical sections

No actual substantive content in Risk Factors, MD&A, or Controls sections

3 more red flags detected

Key Takeaways

Filing appears incomplete or improperly formatted with missing substantive content

Company operates primarily through Malaysian subsidiaries in chemical distribution and gene lab services

2 more takeaways

Filing Overview

Form TypeAnnual Report (10-K)
Filing DateApr 14, 2026
Risk LevelHIGH
TrendDETERIORATING
AI Confidence85%
Red Flags6

What This Means

High Risk Filing: This company is showing signs of financial stress or significant operational challenges.

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.

View Full Filing on SEC.govBrowse More Filings